Stay updated on Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page footer revision shows v3.3.2 replacing v3.3.1, a minor template update that does not affect study details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision update: v3.3.1 was added and v3.2.0 was removed, which does not affect the study details, eligibility criteria, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe government funding status notice was removed; the page content, including study details and eligibility criteria, remains unchanged.SummaryDifference0.4%

- Check43 days agoChange DetectedThe screenshots show no substantive changes to core study information such as conditions, interventions, eligibility criteria, locations, or primary/secondary outcomes. Any differences appear to be in layout or user interface elements rather than the study's primary content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedCore content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.SummaryDifference3%

- Check79 days agoChange DetectedUpgraded from v3.0.2 to v3.1.0 and added new contact/identifier details (phone and email); old version marker removed.SummaryDifference0.1%

Stay in the know with updates to Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.